Dachaigh › Aillse Sgamhain Neo-chealla-beag › Virginia › Arlington
Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Arlington, VA
Tha 104 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Arlington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · 11 mìle air falbh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
A’ fastadhÌre 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mìle air falbh
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
- NEXT Virginia, Fairfax · 11 mìle air falbh
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A’ fastadhÌre 3
- Virginia Cancer Specialists ( Site 0167), Fairfax · 11 mìle air falbh
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
A’ fastadhÌre 2/3
- Virginia Cancer Specialists, PC, Fairfax · 11 mìle air falbh
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
A’ fastadhÌre 3
- Virginia Cancer Specialists ( Site 0114), Fairfax · 11 mìle air falbh
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
A’ fastadhÌre 1
- Site 04, Fairfax · 11 mìle air falbh
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
A’ fastadhÌre 2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
A’ fastadhÌre 1
- ALX Center 2, Fairfax · 11 mìle air falbh
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
A’ fastadhÌre 3
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of PHN-012 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- PHN-012-001 Site, Fairfax · 11 mìle air falbh
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A’ fastadhÌre 3
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
A’ fastadhÌre 2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 1
- Virginia Cancer Specialists PC, Fairfax · 11 mìle air falbh
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
A’ fastadhÌre 2
- Research Site, Fairfax · 11 mìle air falbh
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A’ fastadhÌre 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
A’ fastadhÌre 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mìle air falbh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
A’ fastadhÌre 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mìle air falbh
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 3
- Research Site, Fairfax · 11 mìle air falbh
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A’ fastadhÌre 3
- Clinical Study Site, Fairfax · 11 mìle air falbh
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
A’ fastadhÌre 3
- Virginia Cancer Specialists, Arlington
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A’ fastadhÌre 3
- Virginia Cancer Specialists, PC, Fairfax · 11 mìle air falbh
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
A’ fastadhÌre 1
- NEXT - Virginia, Fairfax · 11 mìle air falbh
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A’ fastadhÌre 2/3
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 mìle air falbh
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
A’ fastadhÌre 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
- Next Oncology Virginia, Fairfax · 11 mìle air falbh
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- Virginia Cancer Specialists (Fairfax) - USOR, Fairfax · 11 mìle air falbh
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A’ fastadhÌre 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mìle air falbh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A’ fastadhÌre 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
A’ fastadhÌre 3
- Research Site, Fairfax · 11 mìle air falbh
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
A’ fastadhÌre 1
- NEXT Oncology, Fairfax · 11 mìle air falbh
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
A’ fastadhÌre 1
- Virginia Cancer Specialists, PC, Fairfax · 11 mìle air falbh
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
A’ fastadhÌre 1
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
A’ fastadhÌre 3
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
A’ fastadhÌre 3
- Research Site, Fairfax · 11 mìle air falbh
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A’ fastadhÌre 2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
A’ fastadhÌre 1
- Inova Schar Cancer Institute, Falls Church · 4 mìle air falbh
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Research Site, Fairfax · 11 mìle air falbh
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
A’ fastadhÌre 3
- Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
- Inova Fair Oaks Hospital, Fairfax · 11 mìle air falbh
A Study of DM005 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Clinical Trial Site, Fairfax · 11 mìle air falbh
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A’ fastadhÌre 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Next Virginia, Fairfax · 11 mìle air falbh
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
A’ fastadhÌre 3
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
A’ fastadhÌre 1/2
- Research Site, Fairfax · 11 mìle air falbh
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A’ fastadhÌre 1
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- Research Site, Fairfax · 11 mìle air falbh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
A’ fastadhÌre 1/2
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
A Study of LY4175408 in Participants With Advanced Cancer
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mìle air falbh
Study of XB010 in Subjects With Solid Tumors
A’ fastadhÌre 1
- Inova Schar Cancer, Fairfax · 11 mìle air falbh
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A’ fastadhÌre 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mìle air falbh
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Research Site, Fairfax · 11 mìle air falbh
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
A’ fastadhÌre 1
- Research Site, Fairfax · 11 mìle air falbh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mìle air falbh
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
A’ fastadhÌre 3
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
A’ fastadhÌre 1/2
- NEXT Oncology, Fairfax · 11 mìle air falbh
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A’ fastadhÌre 1/2
- Next Oncology Virginia, Fairfax · 11 mìle air falbh
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Research Site, Fairfax · 11 mìle air falbh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mìle air falbh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mìle air falbh
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
A’ fastadhÌre 2
- Inova Fairfax Hospital, Fairfax · 11 mìle air falbh
A 2-part Phase 1/2 Open-label Trial on ODM-212
A’ fastadhÌre 1/2
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
A’ fastadhÌre 1
- Research Site, Fairfax · 11 mìle air falbh
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
A’ fastadhÌre 1/2
- NEXT, Virginia, Fairfax · 11 mìle air falbh
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
A’ fastadhÌre 1
- Dren Investigational Site, Fairfax · 11 mìle air falbh
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
A’ fastadhÌre 1
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
A’ fastadhÌre 1
- NEXT Oncology, Fairfax · 11 mìle air falbh
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Research Site 102, Fairfax · 11 mìle air falbh
- Research Site 112, Fairfax · 11 mìle air falbh
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
A’ fastadhÌre 2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile
- Houston, TX145 sgrùdaidhean
- New York City, NY121 sgrùdaidhean
- Nashville, TN97 sgrùdaidhean
- Boston, MA90 sgrùdaidhean
- Los Angeles, CA87 sgrùdaidhean
- St. Louis, MO73 sgrùdaidhean
- Chicago, IL61 sgrùdaidhean
- Baltimore, MD60 sgrùdaidhean
- San Antonio, TX59 sgrùdaidhean
- Columbus, OH57 sgrùdaidhean
- Washington, DC55 sgrùdaidhean
- Seattle, WA53 sgrùdaidhean
Sgrùdaidhean eile ann an Arlington
- Ailse metastatach53 sgrùdaidhean
- Aillse colorectal52 sgrùdaidhean
- Aillse (gach seòrsa)48 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Cancer Ovarian46 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Ailse Endometrial39 sgrùdaidhean
- Cancer Pancreatic33 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil26 sgrùdaidhean
- Ailse sgamhain cealla bheag23 sgrùdaidhean
- Aillse a' Bhroinn20 sgrùdaidhean
- Cancer briste triple-negative20 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.